Skip to main content
OpenTrials
Completed

NCT Number: NCT02787824

Periodic Versus Continuous IV Iron Supplementation in HD Patients

The purpose of this study was to compare the efficacy of two regimens of intravenous iron sucrose [continuous (in every hemodialysis session) versus intermittent (every 1-4 weeks)] on the response of rHuEPO in the maintenance phase of its administration in hemodialysis patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anemia of Chronic Kidney Disease Iron Deficiencies Iron Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Papageorgiou General Hospital

Thessaloniki, 56403, Greece

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Constant rHu-EPO and iron dose for at least 2 months before starting the study
  • Hemoglobin ≥ 8,5g/dl and <12,5 g/dl
  • Ferritin < 1000 mg/dl
  • TSAT < 50%
  • CRP < 5 mg/dl

Exclusion criteria

  • Malignant tumor disease
  • Oral iron supplementation
  • Active bleeding issues
  • Surgical intervention within the last 8 weeks before study inclusion

Treatment and study plan

Iron Sucrose Supplement

Drug

Primary outcomes

  1. Change of serum hemoglobin level (g/dl)

    Time frame: Month 0, 1, 2, 3, 4

Sponsors and collaborators

Lead sponsor

Papageorgiou General Hospital

Other

Registry information

Official study title

Periodic Versus Continuous (at Every Session of Hemodialysis) iv Iron Supplementation in Chronic HD Patients

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Jun 1, 2016
Registry last updated
Sep 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.